State of New Jersey v. P.T. ( 2024 )


Menu:
  •                                       RECORD IMPOUNDED
    NOT FOR PUBLICATION WITHOUT THE
    APPROVAL OF THE APPELLATE DIVISION
    This opinion shall not "constitute precedent or be binding upon any court." Although it is posted on the
    internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.
    SUPERIOR COURT OF NEW JERSEY
    APPELLATE DIVISION
    DOCKET NO. A-1207-23
    STATE OF NEW JERSEY,
    Plaintiff-Appellant,
    v.
    P.T.,1
    Defendant-Respondent.
    _________________________
    Submitted October 2, 2024 – Decided October 28, 2024
    Before Judges Currier, Paganelli and Torregrossa-
    O'Connor.
    On appeal from the Superior Court of New Jersey, Law
    Division, Passaic County, Indictment No. 18-05-0469.
    Camelia M. Valdes, Passaic County Prosecutor,
    attorney for appellant (Lauren P. Haberstroh, Assistant
    Prosecutor, of counsel and on the brief).
    Jennifer N. Sellitti, Public Defender, attorney for
    respondent (Alexandra K. Roche, Assistant Deputy
    Public Defender, of counsel and on the brief).
    1
    We use initials to protect defendant's privacy. Rule 1:38-3(a)(2).
    PER CURIAM
    The State appeals from the December 19, 2023 order dismissing the
    indictment against defendant, P.T., after finding he lacked competency. We
    affirm.
    I.
    A. The Indictments
    When arrested on February 28, 2018, defendant was on pretrial release for
    2017 offenses charged under a separate indictment (Indictment I).2 From the
    time of his February 2018 arrest, defendant has remained detained. In March
    2018, defendant was charged in the indictment underpinning this appeal
    (Indictment II) with two counts of third-degree possession of CDS, N.J.S.A.
    2C:35-10(a)(1), one count of third-degree possession of CDS (heroin) with
    intent to distribute, N.J.S.A. 2C:35-5(a)(1), (b)(3), one count of second-degree
    possession of CDS (cocaine) with intent to distribute, N.J.S.A. 2C:35-5(a)(1),
    2
    Indictment I charged three counts of third-degree possession of a controlled
    dangerous substance (CDS), N.J.S.A. 2C:35-10(a)(1), three counts of third-
    degree possession of CDS with intent to distribute, N.J.S.A. 2C:35-5(a)(1),
    (b)(3), three counts of third-degree possession of CDS with intent to distribute
    within 1000 feet of school property, N.J.S.A. 2C:35-5(a)(1), -7(a); three counts
    of second-degree possession of CDS with intent to distribute within 500 feet of
    a public housing facility, park, or building, N.J.S.A. 2C:35-5(a)(1), -7.1(a), and
    one count of fourth-degree resisting arrest, N.J.S.A. 2C:29-2(a)(2).
    A-1207-23
    2
    (b)(2), and two counts of third-degree possession of CDS with intent to
    distribute within 1,000 feet of school property, N.J.S.A. 2C:35-5(a), -7(a).
    B. The Competency Determinations
    Competency questions concerning defendant's fitness to stand trial
    originated during the January 2019 jury selection for trial on Indictment I when
    it appeared defendant had difficulty understanding and communicating with
    counsel. The trial court ordered a competency evaluation, which was conducted
    on February 4, 2019, by Paul Dasher, Ph.D. Dr. Dasher recommended the case
    be adjourned to gather more information and rule out malingering and conducted
    another evaluation on February 14, 2019. His report opined that "defendant
    [was] not competent[] as there [was] an underlying psychiatric disorder that
    significantly impair[ed] his ability to consult with counsel and assist in his own
    defense." Dr. Dasher stated that with "proper medication and treatment," there
    was a "reasonable expectation" that defendant could regain competence.
    Defendant refused to take any medication.
    The trial court thereafter ordered another competency evaluation to further
    "determine defendant's capacity to understand the proceedings against him and
    to assist in his own defense."
    A-1207-23
    3
    Tarmeen Sahni, Ph.D., conducted the next evaluation in April 2019 and
    issued a report in May 2019. Dr. Sahni noted defendant, without medication,
    was able to engage in "coherent discussion" and express a "rational
    understanding . . . [of] the legal system." The doctor diagnosed defendant with
    delusional disorder, but found him competent to stand trial and "oriented to
    person, place, time, and situation," understanding the roles of the judge,
    prosecutor, defense attorney, and jury. Finding defendant also understood his
    right to testify and the concept of plea bargaining, Dr. Sahni opined that any
    confusion regarding the trial process was from lack of experience. Dr. Sahni
    found defendant presented "low risk of dangerousness to [him]self [and] others,"
    but explained that return to the community and his "homeless status" might
    cause defendant to deteriorate without supervision. After a hearing in July 2019,
    the trial court found defendant fit to stand trial.
    Trial on Indictment I commenced soon after, and a jury found defendant
    guilty on nine of thirteen counts on September 5, 2019. See State v. P.T., No.
    A-1602-19 (App. Div. Mar. 8, 2023) (slip op. 1-4). The court ordered another
    competency evaluation prior to sentencing, which was again conducted by Dr.
    Dasher in October 2019, who determined defendant was competent to proceed
    having demonstrated his "understand[ing of] basic legal concepts." Although
    A-1207-23
    4
    defendant was "not accessing any mental health treatment . . . [and was] not on
    any psychotropic medication," he "still ha[d] the requisite adjudicative
    competence."
    Thereafter, on Indictment I, the court, after merger, imposed an aggregate
    sentence of ten years' imprisonment with five years' parole ineligibility. We
    affirmed the conviction but remanded for resentencing on a merger error. See
    P.T., slip op. at 1-4.
    As Indictment II proceeded before a new trial judge, competency
    questions again emerged, and the judge ordered a new evaluation.           Heidi
    Camerlengo, Ed.D., evaluated defendant on two occasions—once in March 2020
    and a second time in August 2021—and rendered a report in October 2021
    finding he lacked competency to stand trial.3 Dr. Camerlengo found defendant
    did not understand his present legal situation, specifically that he was in a
    criminal court charged with criminal offenses, was unable to orient himself to
    the facts of the offense due to his delusional thought process, and was unable to
    participate in presenting his defense.
    3
    The COVID-19 pandemic and the applicable health restrictions in place at
    Ann Klein Forensic Center (AKFC) and in state prison caused a delay in
    competency evaluations and proceedings and a large interval of time elapsed
    between Dr. Camerlengo's evaluations and her report.
    A-1207-23
    5
    Dr. Camerlengo further opined defendant "[did] not appear capable of
    communicating relevant information to his attorney" or capable of "utilizing
    appropriate decision-making skills related to his legal issues due to his
    delusional thought process." Although defendant "might benefit from a trial of
    antipsychotic medication to address his delusional thought process ," Dr.
    Camerlengo noted he "ha[d] consistently refused to accept psychotropic
    medication, and some practitioners question[ed] whether it would be effective
    in addressing his delusions."
    On November 4, 2021, defendant's prison physician approved the
    involuntary administration of antipsychotic medication to defendant which
    continued until March 2023. In May 2022, Dr. Camerlengo again evaluated
    defendant for competency, observing defendant's "presentation during this
    evaluation appear[ed] to be related to his mental illness that seem[ed] to have
    only partially responded to treatment."     The corresponding report detailed
    defendant's "fixed delusions" despite his "psychotropic medication," noting the
    medication was changed at one time when defendant had negative physical side
    effects. Dr. Camerlengo could not determine defendant's fitness to stand trial
    because of "his unwillingness to cooperate . . . which [was] likely due to mental
    incompetence" and recommended "inpatient psychiatric hospitalization . . . to
    A-1207-23
    6
    facilitate stabilization" and ultimately determine whether defendant could be
    restored to competence.
    Defendant was transferred to AKFC in April 2023 for treatment and
    further evaluation. Douglas Smith, M.D., evaluated defendant and issued a
    report in May 2023, finding defendant incompetent to stand trial but also
    deeming it "substantially probable" that treatment with antipsychotic medication
    would restore him to competence "in the foreseeable future."               As to
    dangerousness, the report noted that there were no "behavioral issues" since
    defendant's arrival at AKFC.
    Pursuant to the court's May 2023 order, Dr. Smith re-evaluated defendant
    and issued a report in September 2023 again concluding defendant was not fit
    to proceed to trial. Finding defendant still exhibited delusions interfering with
    his ability to participate in his defense, Dr. Smith again opined that defendant
    presented no behavioral issues and concluded "[i]t is substantially probable that,
    with treatment with antipsychotic medication, [defendant] would attain fitness
    in the foreseeable future."
    The court then conducted a competency hearing in September 2023, with
    Dr. Smith testifying as to his findings. Dr. Smith recommended medication as
    a significant component for restoration, but explained that defendant refused to
    A-1207-23
    7
    cooperate. AKFC did not administer involuntary medication because defendant
    did not meet the facility's criteria in that defendant did not pose a foreseeable
    risk of danger to himself or others. Consistent with his September 2023 report,
    Dr. Smith explained defendant did not appreciate the nature or gravity of his
    legal situation due to his delusional condition.
    Dr. Smith agreed that it is generally accepted that those with delusional
    disorders can be responsive to antipsychotic medication, but acknowledged
    potential side effects ranging in severity can result from antipsychotic
    medication, including sedation that might interfere with the ability to
    communicate and cause difficulty remaining alert. The doctor opined that
    medication does not typically interfere with memory absent a high dosage and
    the process at AKFC is to monitor the dosage of medication, with dosage
    adjusted or changed altogether upon negative side effects. Nonetheless, Dr.
    Smith indicated that there's always a risk of side effects, and it was not possible
    to eliminate them entirely.
    At the conclusion of the competency hearing, the judge inquired about the
    criteria for ordering involuntary medication, and defense counsel identified the
    four considerations set forth in Sell v. United States, 
    539 U.S. 166
    , 180-82
    (2003), for court-ordered forcible medication. Defense counsel then indicated
    A-1207-23
    8
    she would be filing a motion to dismiss Indictment II and signaled that defendant
    was eligible for parole on his sentence on Indictment I. Both counsel and the
    court concurred that should the court dismiss Indictment II, AKFC could initiate
    involuntary commitment if justified. No order was issued for a new evaluation.
    C. Motion to Dismiss Indictment II
    Defendant filed a motion to dismiss Indictment II under N.J.S.A. 2C:4-
    6(c), which was argued in December 2023. The court asked that counsel address
    the issue of involuntary medication under the factors set forth in Sell, 539 U.S.
    at 180-82, further clarified in State v. R.G., 
    460 N.J. Super. 416
    , 428-31 (App.
    Div. 2019).
    Defense counsel asserted that the State had not moved for involuntary
    medication of defendant and defendant did not meet the involuntary medication
    standard. Counsel argued: the governmental interest in prosecuting defendant
    was substantially diminished by the length of time he had been incarcerated
    pretrial; involuntary medication could have a negative impact on defendant's
    functioning at trial; involuntary medication is not necessary or medically
    appropriate; and AKFC had determined defendant did not meet the medical
    criteria to be medicated against his will.
    A-1207-23
    9
    In addressing dismissal under the N.J.S.A. 2C:4-6(c) factors, defense
    counsel claimed: it was unlikely that defendant, incompetent since October
    2019, would regain competence in the near future; defendant did not regain
    competency during the time he was involuntarily medicated starting in 2021 and
    until March 2023; defendant had been institutionalized for a lengthy period of
    time (almost six years); the charges, although serious, were non-violent, and the
    most serious second-degree charges related to the alleged cocaine found on
    defendant would likely be dismissed as the lab results were negative for that
    substance; the prejudice to the State resulting from further delay in a drug case
    would be lessened by the ability to refresh the memories of largely police
    witnesses with reports; defendant had been, by contrast, greatly prejudiced by
    his years of pretrial detention impacting his constitutional right to a speedy trial;
    and the public interest in prosecuting the case is lessened as the lengthy pretrial
    incarceration has accomplished any necessary deterrent effect.
    The State contended the statutory presumption against dismissal and the
    circumstances of the case favored holding the charges in abeyance. Specifically,
    the State claimed: involuntary medication could help to restore competency; the
    offense of distributing CDS is very serious and offenders must be held
    accountable; the State's plea offer was irrelevant as the charges could be held in
    A-1207-23
    10
    abeyance as long as that delay did not exceed the maximum sentencing term;
    there would be no prejudice to the State by holding the charges in abeyance; and
    any prejudice to defendant was and would be lessened by his simultaneously
    serving another sentence.
    The State conceded it had not moved for involuntary medication of
    defendant, but argued in favor of such an order, contending there is a strong
    governmental interest in prosecuting and deterring drug offenders; any side
    effects from involuntary medication such as sedation could be monitored and
    managed; and restoring defendant to competency would be in his best interest .
    The court then questioned defendant directly, inquiring generally about
    the proceedings and his condition. Defendant's responses reflected his lack of
    understanding of his situation including his belief that he was a "high court
    judge" who "went to school to be a judge" at Seton Hall University and "these
    cases were resolved already."
    Assessing dismissal versus abeyance, the court first acknowledged the
    statutory presumption that it could hold charges in abeyance unless it finds
    "continuation . . . would   constitute   a    constitutionally   significant   injury
    to . . . defendant attributable to undue delay in being brought to trial." N.J.S.A.
    2C:4-6(c). The court found the first four factors under N.J.S.A. 2C:4-6(c)
    A-1207-23
    11
    favored dismissal. First, the court found it could not "determine with any
    definitiveness that [defendant] will return to competency" and noted defendant
    was "found incompetent more than he has been found competent" and defendant
    now appeared incompetent. The court next acknowledged defendant has been
    "sitting in jail . . . since 2018" and "[t]hat's a long time to be incarcerated."
    Further, the court recognized the seriousness of the offenses, but noted if
    defendant had accepted the State's plea offer of a concurrent sentence to that
    which he is serving on Indictment I, he would be eligible for parole. Considering
    the next factors, the court accepted there would be no adverse impact on the
    prosecution if there were further delay, but found there might be an adverse
    effect on defendant if witnesses were to be called by defendant. The court
    explained that defendant may not have "witnesses . . . that would testify for him"
    and "if there are witnesses . . . they don't have . . . reports to rely upon."
    The court declined to order involuntary medication, finding "even if
    [defendant] were to receive involuntary medication, there's no guarantee [it
    would] bring [defendant] up to speed." Recognizing that AKFC found defendant
    did not meet the internal criteria for involuntary medication because he did not
    pose a danger to himself or others, the court was concerned about imposing
    involuntary medication. Although clearly identifying the public interest in
    A-1207-23
    12
    prosecuting "selling drugs," the court questioned whether society has that same
    interest in "punishing someone" who is incompetent. Further, the court found
    defendant had already been "reasonably punished for the crime," observing
    again that the case might have been resolved by plea agreement favorably to
    defendant if he had been competent enough to consider the State's plea offer.
    The court found defendant incompetent and dismissed the indictment,
    issuing an order of dismissal on December 19, 2023. The court further ordered
    defendant remain at AKFC until his next appearance in January 2024 and
    ordered that AKFC provide the court with a treatment plan for defendant prior
    to that appearance. The State appealed.
    II.
    The State raises the following arguments on appeal:
    POINT I
    THE TRIAL COURT ABUSED ITS DISCRETION BY
    DISMISSING    INDICTMENT       18-05-0469-I
    BECAUSE DEFENDANT DID NOT OVERCOME
    THE PRESUMPTION IN FAVOR OF HOLDING
    PROCEEDINGS IN ABEYANCE.
    POINT II
    THE TRIAL COURT COMMITTED CLEAR ERROR
    BY REFUSING TO INVOLUNTARILY MEDICATE
    DEFENDANT WHERE THE STATE SATISFIED
    ALL FACTORS UNDER SELL V. UNITED STATES
    A-1207-23
    13
    BY CLEAR AND CONVINCING EVIDENCE (
    539 U.S. 166
     (2003)).
    As to Point I, the State asserts the court abused its discretion by finding
    defendant was unlikely to regain competency because defendant was deemed
    competent in 2019, and over the next four years consistently displayed at least
    some understanding of the court process. The State further contends the court
    did not consider defendant was serving a ten-year sentence under Indictment I
    and gave improper weight to factor four in favor of dismissal by improperly
    focusing on the plea offer of a concurrent sentence. In addition, the State
    asserted its strong public interest in prosecuting CDS distribution offenses and
    the court erred in finding defendant had been "reasonably punished" in light of
    his history of CDS-related offenses.
    As to Point II, the State contends the court erred in refusing to order
    involuntary medication as the State established all of the Sell factors by clear
    and convincing evidence.
    Defendant counters that the court appropriately considered the arguments
    under each N.J.S.A. 2C:4-6(c) factor and reasonably exercised its discretion in
    dismissing the indictment, appropriately finding a constitutionally significant
    injury to defendant by the continued prosecution despite defendant's
    incompetence. That defendant was serving a sentence on Indictment I, and
    A-1207-23
    14
    COVID-19 concerns delayed defendant's evaluations does not minimize the
    constitutional and speedy trial concerns in defendant's case.
    Defendant further argues that although the State did not move for
    involuntary medication, the court properly analyzed and rejected forcibly
    medicating defendant under the applicable legal standard.
    III.
    We review "[a] trial court's decision denying defendant's motion to
    dismiss [an] indictment . . . for abuse of discretion." State v. Saavedra, 
    222 N.J. 39
    , 55 (2015). Such "discretionary power will not be disturbed on appeal 'unless
    it has been clearly abused.'" Id. at 55-56 (quoting State v. Warmbrun, 
    277 N.J. Super. 51
    , 60 (App. Div. 1994)). We will intervene to correct an abuse of
    discretion only when the "decision is 'made without a rational explanation,
    inexplicably departed from established policies, or rested on an impermissible
    basis.'" State v. Chavies, 
    247 N.J. 245
    , 257 (2021) (quoting State v. R.Y., 
    242 N.J. 48
    , 65 (2020)).
    A defendant who "lacks capacity to understand the proceedings against
    him or to assist in his own defense" cannot be convicted of an offense "so long
    as such incapacity endures." N.J.S.A. 2C:4-4(a). Competency determinations
    are the sole province of the court, and upon a finding of a defendant's
    A-1207-23
    15
    incompetence, when a defendant "has not regained fitness to proceed within
    three months" following the court's initial determination of incompetency, the
    court must consider whether to dismiss the charges with prejudice or hold further
    proceedings in abeyance. N.J.S.A. 2C:4-6(c).
    N.J.S.A. 2C: 4-6(c) further provides a presumption that charges be held
    in abeyance upon a finding of continued incompetency, which "can be
    overcome" if the court, utilizing statutorily enumerated factors, finds further
    delay "would constitute a constitutionally significant injury to the defendant
    attributable to undue delay in being brought to trial." The factors to be weighed
    include:
    [1] the defendant's prospects for regaining competency;
    [2] the period of time during which the defendant has
    remained incompetent; [3] the nature and extent of the
    defendant's institutionalization; [4] the nature and
    gravity of the crimes charged; [5] the effects of delay
    on the prosecution; [6] the effects of delay on the
    defendant, including any likelihood of prejudice to the
    defendant in the trial arising out of the delay; and [7]
    the public interest in prosecuting the charges.
    [N.J.S.A. 2C:4-6(c).]
    Dismissal is appropriate "when it is determined that an adequate period of
    time has elapsed during which the defendant has been institutionalized and has
    remained unfit to be tried." State v. Gaffey, 
    92 N.J. 374
    , 389 (1983). "[T]he
    A-1207-23
    16
    real or likely prejudice to the rights of the defendant that can actually be shown
    or reasonably be inferred from the delay in bringing the matter to trial " aids
    courts in determining the adequacy of time.       
    Ibid.
       This court has further
    recognized that
    [w]hile elemental fairness and due process
    considerations are applicable to avoid constitutionally
    significant injury attributable to undue delay, the
    validity of claims relating to speedy trial should be
    made on a case-by-case basis in terms of the prejudice
    to defendant's rights that can actually be shown or
    reasonably be inferred from the delay.
    [State v. Moya, 
    329 N.J. Super. 499
    , 514 (App. Div.
    2000).]
    A court's consideration "requires more than mere reliance upon the length of
    time elapsed." 
    Ibid.
    Here we discern no basis for disturbing the court's order dismissing the
    indictment. Recognizing the presumption against dismissal, the court properly
    considered the N.J.S.A. 2C:4-6(c) factors and found that it could not determine
    that defendant was likely to regain competence, and further delay would exact
    enduring constitutionally significant injury to defendant. That conclusion was
    grounded in the record.
    A-1207-23
    17
    The court observed that, despite being found competent early in the
    proceedings, defendant currently appeared to be incompetent, had been found
    incompetent more times than competent, and remained incompetent since 2019.
    It found that the nearly six years defendant was incarcerated pretrial and the
    nature and extent of his institutionalization, during which defendant was both
    unmedicated and medicated in both prison and hospital settings, supported
    dismissal.
    The court analyzed the nature and gravity of the crimes charged,
    recognizing the seriousness of drug distribution. We find no error in the court's
    noting the State's plea offer to recommend a sentence concurrent to his sentence
    on Indictment I would likely have already rendered defendant parole eligible.
    The court also considered the diminished prejudice to the State by further
    delay noting memories could be refreshed by police reports created at the time
    of the drug offenses, but found defendant faced greater potential prejudice with
    the passage of time because any witnesses he may have decided to call to testify
    would likely be unable to rely on similar reports.
    Finally, the court recognized there is "absolutely" a public interest in
    prosecuting drug distribution charges, but reasonably considered the
    circumstances of defendant's situation, specifically his lengthy incarceration and
    A-1207-23
    18
    consistent incompetence. Thus, we will not disturb the court's determination as
    the court recognized each statutory factor and anchored its decision in the
    record.
    IV.
    We turn to the State's contention that the court erred in not entering an
    order for involuntary medication.     We recognize the State made no formal
    application for forced medication, and the trial court raised the issue. We
    nevertheless determine that the State received ample notice of the issue at the
    competency hearing and argued in support of an involuntary medication order,
    after which the court properly addressed the applicable legal standards and
    rooted its factual determinations in the record.
    "In light of the constitutional rights at stake on a motion to involuntarily
    medicate a defendant to restore competency," the court's "legal determinations
    on a Sell application are reviewed de novo while its factual findings are
    reviewed for clear error" under Rule 2:10-2. State v. J.H.P., 
    478 N.J. Super. 262
    , 278 (App. Div. 2024). In assessing clear error, we may "not reverse the
    findings of the [motion] court simply because [we] would have weighed the
    evidence differently." 
    Id. at 276
     (alteration in original) (quoting United States
    v. Coy, 
    991 F.3d 924
    , 929 (8th Cir. 2021)).
    A-1207-23
    19
    In Sell, the Supreme Court set forth a four-part test in evaluating for
    involuntary medication of a defendant who has not yet been convicted of a
    crime, holding:
    [T]he      Constitution     permits the       Government
    involuntarily to administer antipsychotic drugs to a
    mentally ill defendant facing serious criminal charges
    in order to render that defendant competent to stand
    trial, but only if the treatment is medically appropriate,
    is substantially unlikely to have side effects that may
    undermine the fairness of the trial, and, taking account
    of less intrusive alternatives, is necessary significantly
    to further important government trial-related interests.
    [539 U.S. at 179.]
    Specifically, to satisfy the standard in Sell, a court must find by clear and
    convincing evidence that 1) important governmental interests are at stake; 2)
    involuntary medication will significantly further those interests; 3) involuntary
    medication is necessary to further those interests; and 4) administration of the
    drugs is medically appropriate, or in the patient's best interest in light of his
    medical condition. Id. at 180-82; see also State v. R.G., 460 N.J. Super. at 429
    n.5.
    The governmental interest is strong when the prosecution involves "a
    serious crime against the person or a serious crime against property," and courts
    must also consider special circumstances that "may lessen the importance of
    A-1207-23
    20
    [the] interest," such as the potential for future confinement and whether the
    defendant has already been confined for a significant amount of time. Sell, 539
    U.S. at 180. Also, "lengthy confinement in an institution for the mentally
    ill . . . would diminish the risks that ordinarily attach to freeing without
    punishment one who has committed a serious crime."           Ibid.   We further
    narrowed the scope of this consideration in R.G., 460 N.J. Super. at 430,
    "agree[ing] . . . that Sell's first factor is not informed by defendant's maximum
    [sentencing] exposure but by defendant's probable sentence if convicted."
    Here, the trial court properly applied the legal standards to the record.
    Specifically, the court found that prosecuting drug distribution is an important
    governmental interest, but also recognized that defendant was not charged with
    violent crimes. We perceive no error in the court's finding that the State's
    interest in prosecution diminishes when considering defendant's incarceration
    since February 2018, through a worldwide pandemic, which certainly exacted a
    deterrent impact. We note that defendant's likely sentence if convicted would
    be reduced, given the apparently undisputed laboratory testing removing any
    potential second-degree exposure.
    Further, as the trial court stated, AKFC professionals did not determine
    defendant to be dangerous to himself or others, and although applying its own
    A-1207-23
    21
    internal clinical standard, found forcible medication unwarranted in defendant's
    case. The court did not err in determining these findings of non-dangerousness
    diluted the governmental interest in prosecution.
    We also recognize the record did not support, by clear and convincing
    evidence, that involuntary medication was necessary to further the interests in
    continued prosecution. Under Sell, the "administration of the drugs [must be]
    substantially likely to render the defendant competent to stand trial," and
    "substantially unlikely to have side effects that will interfere significantly with
    defendant's ability to assist counsel in conducting a trial defense . . . ." Sell, 539
    U.S. at 181.
    Here, the court addressed Dr. Smith's opinion that involuntary medication
    had a "substantial probability" of restoring defendant, weighing that opinion in
    conjunction with the record. We discern no error in the court's recognizing that
    defendant had been involuntarily medicated for a substantial period of time
    between 2021 and 2023, yet his evaluations during that period revealed
    defendant remained delusional, only "partially responded to treatment," and had
    an unwillingness to cooperate likely due to his mental illness. Further, the court
    noted the testimony that experimenting with medication could cause side effects
    like sedation that might be detrimental to defendant and his ability to engage in
    A-1207-23
    22
    the trial process. We note that the record also reflects that defendant was not
    medicated during his small window of competence in 2019.
    As the record lacked clear and convincing evidence that forced medication
    would restore defendant without medical side effects and advance the
    government interest, the court reasonably declined to enter such an order. The
    Supreme Court in Sell warned its standard would permit involuntary
    administration of drugs for trial competence purposes, but "[these] instances
    may be rare." Id. at 180. We are satisfied defendant's is not one of those unique
    cases.
    Affirmed.
    A-1207-23
    23
    

Document Info

Docket Number: A-1207-23

Filed Date: 10/28/2024

Precedential Status: Non-Precedential

Modified Date: 10/29/2024